What began as joyful anticipation of a fourth child became a journey no family expects. Little Tessa entered the world with Down syndrome—an extra chromosome that brought both profound love and new uncertainties for her parents and siblings.

She spent her first 11 days in the neonatal intensive care unit and left the hospital with supplemental oxygen, but otherwise appeared to be in good health. For a time, life settled into the rhythms of a busy household filled with older brothers and sisters. Tessa’s cheerful nature and bright smile quickly became a source of light for everyone around her.

That changed when she was 18 months old. Multiple infections that would not clear, growing lethargy, and the disappearance of her usual spark prompted her pediatrician to order blood tests. The results confirmed acute lymphoblastic leukemia (ALL), a blood cancer. Children with Down syndrome face a markedly higher risk of developing leukemia than other children, a reality the family now confronted head-on.

What followed were two and a half years of intensive chemotherapy. The treatments were grueling. Medications left Tessa extremely ill and, on more than one occasion, brought her close to losing her life. Hospital visits, long stays, and sleepless nights became part of the family’s routine as they remained by her side. Through it all, Tessa never lost her light. Her gentle yet powerful smile continued to comfort those around her and reminded her parents and siblings of the quiet strength that can live in even the smallest of bodies.

In May 2020, Tessa completed treatment. Her story is not only one of difficult medical days, but of courage, steady love, and a spirit that refused to fade. She showed her family—and everyone who followed her journey—that true strength is not measured by size or age, but by the heart. Sometimes the smallest souls carry the brightest light.

Sources

• Blood Cancer United patient story and family account of Tessa’s birth with Down syndrome, diagnosis of acute lymphoblastic leukemia at 18 months, and completion of 2.5 years of chemotherapy in May 2020
• Related awareness materials noting the elevated risk of leukemia in children with Down syndrome